Drugmaker’s $29.6M settlement includes claim money for customers

Global drug manufacturer Glenmark Pharmaceuticals has agreed to pay $29.6 million to settle a lawsuit filed by dozens of states.

Healthcare Finance News reports that Glenmark was accused of colluding with other companies to fix the prices of generic prescription drugs sold nationwide. These increased for medication needed for ailments ranging from cancer to ADHD by as much as 1,000 percent, the New York State Attorney General's Office states .

Glenmark has also agreed to implement an antitrust compliance program that involves annual training for sales and management employees. It will also continue to work with state officials in the continuing litigation against other drugmakers .

According to t he settlement website , anyone who purchased generic prescription drugs manufactured by any of the companies involved in the lawsuit between May 1, 2009, and Dec. 31, 2019, could be eligible to file a claim for compensation.

These drugs include brand names such as Differin, Adderall, and Lotrisone. The full list can be found here.

The claims process for the Glenmark process has not yet begun. Potential claimants can register with the settle administration at the above link in order to be notified when the claims process will begin.

The information regarding each lawsuit pertaining to the other drug manufacturers involved in these accusations can be found here . Claims for the currently listed settlements must be filed online or sent by mail by Nov. 9.

The states ant territories involved in these lawsuits are :

• Alaska

• Arizona

• California

• Colorado

• Connecticut

• Delaware

• Florida

• Georgia

• Idaho

• Illinois

• Indiana

• Iowa

• Kansas

• Kentucky

• Maine

• Maryland

• Massachusetts

• Michigan

• Minnesota

• Mississippi

• Montana

• Nebraska

• Nevada

• New Hampshire

• New Jersey

• New Mexico

• North carolina

• North Dakota

• Ohio

• Oklahoma

• Oregon

• Pennsylvania

• Rhode Island

• South Carolina

• South Dakota

• Tennessee

• Utah

• Vermont

• Virginia

• Washington

• Washington, D.C.

• West Virginia

• Wisconsin

• Wyoming

• Northern Mariana Islands

• Puerto Rico

• The U.S. Virgin Islands

How much the claims from the Glenmark settlement will be for each customer has yet to be confirmed.

More Health Care News from MassLive

• CVS Caremark settlement could save people billions on prescriptions

• The 5 big things for you in the $63.4B that Gov. Maura Healey signed into law

• Medical influencer speaks on Boston hospital strike: 'Love you Massachusetts'

• Millions of Americans now eligible for GLP-1 medication at $50 a month: How to apply

Read the original article on cleveland.com . Add cleveland.com as a Preferred Source by clicking here .